Supriya Lifescience Shares Surge Over 16 After Strong Q4FY26 Results PAT Up 47 Revenue Jumps 50 AMCX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines US Seeks Stable Equilibrium With China Defense Nominee Hegseth Signals Strategy Shift